Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
KAHR Medical is an Israeli biotech company developing a drug platform known as DSP (Dual Signaling Proteins), bi-functional fusion proteins that are based on the TNF-superfamily, the proteins that control the immune system. KAHR's technology allows t...Show all
Company (Alive / Active)
Phone: +972 737969196
1 Kiryat Hadassah JPG Bdlg.
Jerusalem, 9109701
Israel
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Stable form of signal converting protein fusion proteins, and methods of use and preparation thereof | Dec 31, 2013 | Aug 07, 2018 | Patent |
Compositions and methods for treatment of hematological malignancies | Jun 09, 2016 | Jun 19, 2018 | Patent |
Compositions and methods for treatment of hematological malignancies | Sep 28, 2011 | Jul 12, 2016 | Patent |
Stable form of signal converting protein fusion proteins, and methods of use and preparation thereof | Jul 05, 2018 | Application | |
Sirpalpha-41bbl fusion protein and methods of use thereof | Jan 04, 2018 | Application |